• Beam Therapeutics' (BEAM) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

    المصدر: Buzz FX / 13 مارس 2025 10:46:17   America/Chicago


    Beam Therapeutics' (BEAM) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) 's stock had its "overweight"
    Read more...
شارك على،